Skip to main content

Year: 2026

Genmab Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

Media Release COPENHAGEN, Denmark; July 6, 2026TEPKINLY® (epcoritamab) plus lenalidomide and rituximab (R2) is the first and only bispecific-based therapy approved in Europe for the treatment of follicular lymphoma in the second-line setting, offering a chemotherapy-free optionIn the Phase 3 EPCORE® FL-1 trial, fixed-duration TEPKINLY + R2 demonstrated significantly superior progression-free survival and overall response rates compared to R2, with approximately three out of four patients achieving a complete responseGenmab A/S (Nasdaq: GMAB) announced today that the European Commission (EC) granted marketing authorization for TEPKINLY® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R2) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL). The approval is based on...

Continue reading

HII is Awarded Option Year Contract for U.S. Navy Lionfish Unmanned Undersea Vehicle Production

POCASSET, Mass., July 06, 2026 (GLOBE NEWSWIRE) — HII, a global leader in autonomous unmanned maritime systems, has been awarded an option year production contract for the U.S. Navy’s next-generation program of record, the Lionfish small unmanned undersea vehicle (SUUV). Lionfish is based on HII’s commercial REMUS 300 platform, originally developed as part of a rapid prototyping initiative in collaboration with the U.S. Navy and the Defense Innovation Unit (DIU). Designed to address a broad range of undersea warfare missions, Lionfish supports mine countermeasures, intelligence, surveillance and reconnaissance (ISR), anti-submarine warfare, and electronic warfare operations. This latest option year contract continues to build the momentum of the Lionfish program, which marked a major production milestone at the close of 2025 with...

Continue reading

American Clean Resources Group Receives Letter of Intent for Up to $40 Million in Joint Development Capital to Advance Millers Solar Energy Zone Acquisition

Commitment from Elko Heat Company, a Nevada geothermal utility operating since 1982, builds on the June 2026 Joint Exploration and Development Agreement covering the Millers Property in Esmeralda County, Nevada LAKEWOOD, Colo., July 06, 2026 (GLOBE NEWSWIRE) — American Clean Resources Group, Inc. (OTC: ACRG), a domestic critical minerals and precious metals processing company, today announced that it has received a Letter of Intent from Elko Heat Company (“EHC”), acting in its corporate investing capacity, under which EHC has confirmed its commitment to use commercially reasonable good-faith efforts to arrange and provide up to $40 million in joint development capital. The capital is intended to support ACRG’s pursuit of a Bureau of Land Management (BLM) Solar Energy Zone competitive lease and associated solar...

Continue reading

TPI Composites Successfully Emerges from Chapter 11 under New Ownership; Reaffirms Long-Term Commitment to Wind Energy, Field Services, and Blade Manufacturing

SCOTTSDALE, Ariz., July 06, 2026 (GLOBE NEWSWIRE) — TPI Composites, Inc., a leading independent manufacturer of composite wind blades, today announced that it has successfully completed its financial restructuring and emerged from Chapter 11. Going forward, TPI’s Iowa and Juarez, Mexico manufacturing businesses and its global field services business will continue to be operated under the TPI brand and owned by Energy Capital Partners, a leading private equity firm specializing in energy transition, electrification, and decarbonization infrastructure. With an optimized capital structure, no debt, and the financial backing of ECP, TPI emerges as a leaner, more agile enterprise. Accelerating the North American Wind Market TPI is anchoring its strategy around the robust North American wind energy market. Backed by ECP’s...

Continue reading

Major shareholder announcement pursuant to section 30 of the Capital Markets Act.

Ress Life Investments A/SNybrogade 12DK-1203 Copenhagen KDenmarkCVR nr. 33593163www.resslifeinvestments.comTo: Nasdaq CopenhagenDate: 6 July 2026 Corporate Announcement 24/2026 Major shareholder announcement pursuant to section 30 of the Capital Markets Act. Ress Life Investments A/S has received notification that Longevity Strategy Fund A/S, holds more than 5% of the share capital and voting rights in Ress Life Investments A/S. On 30 June 2026, Longevity Strategy Fund A/S has purchased shares in Ress Life Investments A/S and therefore now holds 8,119 shares in Ress Life Investments A/S with a total nominal value of EUR 4,059,500 corresponding to 6.83% of the total share capital and voting rights in Ress Life Investments A/S.   Questions related to this announcement can be made to the company’s AIF-manager, Finserve Nordic AB. Contact...

Continue reading

Valeo – Voting rights – June 2026

PRESS RELEASEParis, 06 July, 2026 Information on the total number of voting rightsand shares forming the share capital(Article L.233-8 II of the French Commercial Code andArticle 223-16 of the General Regulation of the French Financial Markets Authority)Date Issued capital Par value Total number of shares Total number of voting rightsTheoretical* Exercisable**  June 30, 2026   € 245,607,624 € 1 245,607,624 276,898,916 272,805,978*In accordance with Article 223-11 of the General Regulation of the French Financial Markets Authority, the total number of theoretical voting rights is calculated on the basis of all shares to which voting rights are attached, including shares deprived of voting rights.**The total number of exercisable voting rights is calculated without taking into account shares deprived of voting rights.About...

Continue reading

BUREAU VERITAS – Half-year report on the liquidity contract

PRESS RELEASE Courbevoie, France – July 06, 2026 Half-year report on the liquidity contract Under the liquidity contract entrusted by Bureau Veritas to Rothschild Martin Maurel, as of June 30, 2026, the following assets were held in the liquidity account:10,000 Bureau Veritas shares10,608,832 euros (in cash)In the first half-year of 2026, the following transactions took place:Shares purchased: 3,682,032 shares (13,032 transactions) for a total of 99,341,719.50 eurosShares sold: 3,672,032 shares (13,723 transactions) for a total of 99,044,684.61 eurosIt should be noted that: At the last half-year report date, on December 31, 2025, the following assets were held in the liquidity account:0 Bureau Veritas share10,905,867 euros (in cash)In the second half-year of 2025, the following transactions took place:Shares purchased:...

Continue reading

Egide: Availability of the 2025 Annual Financial Report

, July 06, 2026 (GLOBE NEWSWIRE) — Bollène, France, July 6, 2026 – 6:00pm (CET)Press release Availabilityof the 2025 Annual Financial Report Egide Group (Euronext Growth Paris™- ISIN: FR0000072373 – Ticker: ALGID), a worldwide provider of hermetic packages and interconnection solutions for sensitive electronic components, announces that it has made its Annual Financial Report for the year ended December 31, 2025 available to the public and filed it with the French Financial Markets Authority (AMF). The 2025 Annual Financial Report can be consulted on the Group’s website, www.egide-group.com, in the Finance / Financial information / Financial reports section. The following documents have been included in the 2025 Annual Financial Report:the 2025 activity report, the 2025 consolidated financial statements, the 2025...

Continue reading

Biotalys Notice of Publication Half Year 2026 Financial Results and Business Highlights

Webcast and Conference Call to take place on Thursday, 20 August 2026 at 15:00 CET / 14:00 GMT / 09:00 AM ET Ghent, BELGIUM, July 06, 2026 (GLOBE NEWSWIRE) — Press release Biotalys (Euronext – BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, today announces that it will publish its financial results and business highlights for the first half of 2026 on Thursday, 20 August 2026 at 07:00 CEST. Webcast and Conference Call In addition to the publication of its results, management will host a webcast and conference call followed by a Q&A session, conducted in English. The webcast will be held on Thursday, 20 August 2026 at 15:00 CEST / 14:00 GMT / 09:00 AM ET and can be accessed via the following link:https://edge.media-server.com/mmc/p/akwx4keo. To...

Continue reading

Voltalia SA: Half-year statement of the liquidity contract as of June 30, 2026

Half-year statement of the liquidity contract  As of June 30, 2026 Voltalia (Euronext Paris, ISIN code: FR0011995588), announces that the Company’s liquidity account, which is managed by NATEXIS ODDO BHF under a liquidity contract, included the following cash and Company common shares as of June 30, 2026:39,832 shares €675,514 Number of transactions on buy side over the period: 1,953 Number of transactions on sell side over the period: 1,954 Volume traded on buy side over the period: 702,179 shares for €5,116,001 Volume traded on sell side over the period: 695,284 shares for €5,098,712As a reminder, when the contract started, the following cash and shares were allocated to the liquidity account:30,384 shares €1,000,000Next on the agenda: Q2 2026 turnover, on July 23th (after market hours)About Voltalia (www.voltalia.com)Voltalia...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.